In the Media

Showing 321–360 of 388

Wall Street Journal

Texas Freeze Triggers Global Plastics Shortage

Jupiter Intelligence

What Is Evolv? 'Human Security' Firm Backed by Bill Gates to Go Public in SPAC Merger

Evolv Technology

Element AI raises $151M Series B to help companies build and run AI solutions

Atomwise Raises $123m Series B For Breakthrough Drug Discovery Platform

DCVC Bio Closes $250m Fund for Deep Tech-enabled Life Sciences Companies

The New Yorker Explores How AbCellera's Antibody Therapy Treatment May Be the COVID Cure We're Waiting For

DCVC Leads $53m Caption Health Series B to Make Heart Scans More Accessible

BioBot Analytics Reveals What Your Toilet Flush Uncovers About COVID-19

Wall Street Journal

MIC Helps Houston Methodist Hospitals Reduce ICU Staff Exposure to Covid-19

Kentik CEO Avi Freedman Explains to The Atlantic How We Kept the Internet Running in a Pandemic

Canadian Government Gives AbCellera $125M to Accelerate COVID-19 Antibody Treatment Research

Pivot Bio is Ushering in a Farming Revolution, Closes $100M Series C

Wall Street Journal

Eli Lilly and AbCellera Show Progress for COVID-19 Antibody Therapy Treatment

Fortem Technologies and Community Rally to Supply Utah County’s First Responders with 3D-printed Masks

Fortem Technologies

Eli Lilly CEO Talks Partnering with AbCellera Biologics to Co-develop a Coronavirus Cure

Leather’s Carbon Footprint Is Immense, But Mycoworks Fungal Alternative Could Be the Way Forward

Rocket Lab tests key maneuver needed for reusability during 10th flight to space

Genetic Engineering & Biotechnology News

Cognitive Take on RNA Elevates Biomarker Development, Advances Precision Medicine

Cofactor Genomics

DCVC Partner Kelly Chen Talks About the Latest Trends In Robotics

Rocket Lab Completes Major Milestone In Quest to Make Space More Accessible

DCVC co Embark opens freight transfer hubs for its autonomous trucks as it raises a $70m series c

The Washington Post

Planet Lab, Bloomberg Philanthropies and California team up to track climate pollutants

Frontier Medicines was named one of Fierce Biotech’s Fierce 15 for the work its doing to redefine the course of debilitating diseases, using chemoproteomics and machine learning to discover new medicines.

Frontier Medicines

Forbes looks at Tala Mobile’s quest to expand financial access for the 3b underserved people across the globe - 4 million customers have already borrowed more than $1 billion

Transport Topics

Embark CEO Alex Rodrigues talks to Transport Topics about progress on the way to self-driving trucks

Business Insider

Business Insider looks at all the vehicles Amazon has to deliver packages to your doorstep, including autonomous trucks from Embark

Sara Menker, CEO of DCVC co Gro Intelligence, talks to Fortune about how AI can help feed the world

Atomwise Announces Three More Drug Discovery Partnerships – Driving $6b total value contracts in last 9 months

Gro Intelligence CEO Educates Bloomberg Markets on the state of the world’s pork, corn and soy

Freenome Partners with ADC Therapeutics to Better Understand Patients with Lymphoma

Behind the scenes at the most beautiful, effective and reliable smallsat launch site…ever

DCVC Portfolio Company Tala, which has lent $1 billion to over 4 million customers – raises $110m to continue expanding financial access, choice and control for 3b underserved globally

DCVC’s own Ali Tamaseb tells SynBioBeta how to spot a synthetic biology unicorn

Nature Reviews highlights how companies like DCVC co Recursion are combining cell imaging and machine learning to search for new pharmaceuticals

Recursion Pharmaceuticals

Grointelligence (old)

Gro Intelligence CEO Sara Menker talks ag-tech and the future of farming on Recode Decode with Kara Swisher

DCVC co Zymergen talks about using biology for industrial purposes at scale in Forbes

The Washington Post

Planet Labs imagery shows staggering extent of melting on Greenland ice sheet

GenEngNews talks to DCVC co Zymergen about how synthetic biology is tackling challenges in medicine, food, electronics and more

Newsweek talks to Atomwise CEO Abraham Heifets About His Moonshot – Using AI to Discover Better & Safer Drugs for Cancer Patients

ZDNet talks cell painting, explaining how Recursion Pharmaceuticals is combining sophisticated cell imaging with machine learning to find cures for diseases

Recursion Pharmaceuticals